Drs. Oz and Roizen: Three medications that ease Alzheimer's symptoms

Farha and Tomy have three children, and two of them have a rare and incurable pathology: Sanfilippo disease. Nicknamed "Alzheimer ...

Alzheimer's disease remains incurable to date. However, research efforts have resulted in medication treatments that slow down progression and reduce symptoms. The most recent ones directly target one of the causes of the disease: amyloid plaques. Gantnerumab is one of them. Despite mixed preliminary results, it has been the subject of an open-ended extension study to assess its long-term safety and efficacy. It could ultimately delay the onset …

Drs. Oz and Roizen: Three medications that ease Alzheimer's symptoms

As we wait for a breakthrough that can block or reverse Alzheimer’s disease, there is some consolation that we finally have three kinds of medications and a treatment that can damp down or slow the progression of symptoms — cholinesterase…

Recent research has shown that lack of sleep increases the risk of neurodegenerative diseases, such as Alzheimer’s, by affecting the processes of brain cleansing and regeneration. A study published in Nature Communications reveals that sleeping less than necessary can accelerate the accumulation of toxic proteins in the brain, such as beta-amyloid, a key factor in Alzheimer’s progression. But if you don’t panic, this can be avoided by improving …

Alzheimer’s: A Well-Earned Glimmer of Hope – Patient Worthy

Scientists have earnestly delved into a new study to test a drug for individuals who have genetically inherited a type of early-onset Alzheimer’s disease known as “dominantly inherited Alzheimer’s disease”. Dementia is practically inevitable for this group. The drug that has generated optimism in many cases has eliminated amyloid plaques by fifty percent. Medical News […]

IGC Pharma posts promising interim data for Alzheimer’s therapy

The results suggest that IGC-AD1 may decrease the frequency and severity of sleep disturbances and night time behaviours.The post IGC Pharma posts promising interim data for Alzheimer’s therapy appeared first on Clinical Trials Arena.